首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1456973

全球經腸營養設備市場 – 2024 年至 2029 年預測

Global Enteral Feeding Devices Market - Forecasts from 2024 to 2029

出版日期: 2024年02月05日 | 出版商:

Knowledge Sourcing Intelligence | 英文 165 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

2022年經腸營養設備市場價值為35.23億美元，預計複合年成長率為4.81%，到2029年市場規模將達到48.95億美元。

經腸營養裝置是一種將液體營養物質直接輸送到胃腸道的醫療設備，使患者能夠透過管子獲得必需的營養物質，如蛋白質、碳水化合物、脂肪、維生素和礦物質。這些設備通常用於醫院、長期照護機構和居家醫療環境，以確保營養控制和測量。

這是由於早產兒數量的增加、開發中國家醫療設施的快速改善以及糖尿病、乙型肝炎、丙型肝炎、癌症、類風濕性關節炎、胃腸道疾病等慢性病患病率的上升所推動的。和 CVD。這些因素預計將推動顯著成長。例如，胃腸道和肝臟疾病是中東和北非國家死亡和殘疾的主要原因。阿富汗、巴基斯坦和埃及的 GLD 患者數量最多。在該地區大多數國家，腹瀉病已被胃腸道癌症和肝硬化所取代。然而，在一些國家，包括阿富汗、巴基斯坦、土庫曼斯坦、埃及和也門，除了非傳染性 GILD 和癌症之外，傳染性 GILD 繼續在死亡率和發病率中占主導地位。 GILD患者數量的增加顯著增加了對醫療服務和設備（包括經腸營養設備）的需求。

此外，居家醫療和門診醫療保健中擴大採用經腸營養設備，預計將進一步推動預測期內的顯著成長。然而，與經腸營養設備相關的併發症、經腸營養報銷不足以及消費者對使用經腸營養設備的程序缺乏認知等因素預計將阻礙市場成長。

市場促進因素：

老年人口不斷增加，慢性病盛行率上升。

由於各種神經和肌肉骨骼疾病而臥床不起的老年人口數量不斷增加，預計將進一步推動市場成長。在澳洲等已開發國家，老年人口持續成長，預計到 2057 年將增加一倍以上。這種疾病的盛行率逐年增加，這可能會對經腸營養設備產生巨大的需求。

此外，心血管疾病、糖尿病和癌症等自體免疫疾病的盛行率不斷增加，預計市場對預填充式注射器的巨大需求。根據世界衛生組織 (WHO) 估計，約有 1,790 萬人因心血管疾病增加而死亡，約佔全球死亡人數的 32%。

此外，腹瀉疾病的增加預計也將推動整體市場的成長。據世界衛生組織 (WHO) 稱，腹瀉病每年導致約 525,000 名五歲以下兒童死亡。由於營養不良以及食物和水源污染，腹瀉病是全世界兒童死亡的主要原因。全球有 7.8 億人缺乏飲用水，25 億人缺乏改善的衛生設施。

預計北美將主導整個市場

從地區來看，經腸營養設備市場分為北美、歐洲、中東和非洲、南美和亞太地區。印度和中國等國家預計在預測期內將出現可觀的市場成長。這一成長歸因於糖尿病盛行率的上升，印度20-79歲年齡層的糖尿病患者有7,700萬，其次是中國，有1.16億成年人患有糖尿病。這一成長主要由西太平洋和東南亞國家貢獻（資料來源：IDF）。由於在醫療保健領域採用先進的治療方法，該設備的採用率越來越高，預計北美將主導整個市場的成長。此外，該地區慢性病的高盛行率將進一步增加對經腸營養設備的需求。 2020年，美國估計有186萬人被診斷出罹患癌症，超過55,000人死於癌症（資料來源：美國癌症研究所）。北美經腸營養設備市場預計將受到政府有利的財政支持以及美國持續的研究、預防和治療的推動。

介紹
消化內科
- 市場機會和趨勢
- 成長前景
- 地域盈利
瘤
- 市場機會和趨勢
- 成長前景
- 地理收益
神經病學
- 市場機會和趨勢
- 成長前景
- 地域盈利
代謝亢進
- 市場機會和趨勢
- 成長前景
- 地域盈利
糖尿病
- 市場機會和趨勢
- 成長前景
- 地理收益
其他
- 市場機會和趨勢
- 成長前景
- 地域盈利

第8章經腸營養設備的全球市場：依最終用戶分類

介紹
醫院
- 市場機會和趨勢
- 成長前景
- 地域盈利
居家醫療
- 市場機會和趨勢
- 成長前景
- 地域盈利
門診就診環境
- 市場機會和趨勢
- 成長前景
- 地域盈利

第9章經腸營養設備全球市場：按地區

介紹
北美洲
- 按類型
- 按年齡層別
- 按用途
- 按最終用戶
- 按國家/地區
南美洲
- 按類型
- 按年齡層別
- 按用途
- 按最終用戶
- 按國家/地區
歐洲
- 按類型
- 按年齡層別
- 按用途
- 按最終用戶
- 按國家/地區
中東/非洲
- 按類型
- 按年齡層別
- 按用途
- 按最終用戶
- 按國家/地區
亞太地區
- 按類型
- 按年齡層別
- 按用途
- 按最終用戶
- 按國家/地區

第10章競爭環境及分析

主要企業及策略分析
市場佔有率分析
合併、收購、協議和合作
競爭對手儀表板

第11章公司簡介

GBUK Enteral Ltd.
Nestle SA
B.Braun Melsungen AG
Cardinal Health, Inc.
維貢（英國）有限公司
Avanos Medical, Inc.
Rockfield Medical Device
Applied Medical Technology, Inc.
Fresenius SE & Co. KGaA
Conmed Corporation
Moog Inc.

簡介目錄

Product Code: KSI061611549

The global enteral feeding devices market is evaluated at US$3.523 billion for 2022 and is projected to grow at a CAGR of 4.81% to reach the market size of US$4.895 billion by 2029.

Enteral feeding devices are medical devices that deliver liquid nutrients directly into the gastrointestinal tract, allowing patients to receive essential nutrients like proteins, carbohydrates, fats, vitamins, and minerals through a tube. These devices are commonly used in hospitals, long-term care facilities, and home healthcare settings to ensure controlled and measured administration of nutrition.

Factors that are expected to drive this notable growth are an increasing number of premature births, rapid improvements in medical facilities in developing countries, and the rising prevalence of chronic diseases like diabetes mellitus, hepatitis B and C, cancer, rheumatoid arthritis, gastrointestinal disease, and CVDs. For instance, gastrointestinal and liver diseases are major causes of death and disability in the Middle East and North African countries. The number of patients suffering from GLDs is highest in Afghanistan, Pakistan, and Egypt. Diarrheal diseases have been replaced by gastrointestinal cancers and cirrhosis in most countries in the region. However, in several countries including Afghanistan, Pakistan, Turkmenistan, Egypt, and Yemen, communicable GILDs are still among the top causes of mortality and morbidity in addition to non-communicable GILDs and cancers. The rising prevalence of GILD cases has significantly increased the demand for healthcare services and equipment, including enteral feeding devices.

Moreover, the rising adoption of enteral feeding devices in the home and ambulatory care settings is further projected to drive this notable growth during the forecast period. However, factors such as complications associated with enteral feeding devices, insufficient reimbursement for enteral nutrition, and lack of consumer awareness for procedures using enteral feeding devices are expected to hinder market growth.

MARKET DRIVER:

Growing geriatric population and rise in prevalence of chronic diseases.

A rising geriatric population that gets bedridden due to various neurological and musculoskeletal disorders is further expected to boost the market growth. In developed countries like Australia, the older population continues to grow and is projected to more than double by 2057. The prevalence of the disease is rising from year to year which will create a huge demand for enteral feeding devices.

Further, the rising prevalence of autoimmune diseases such as cardiovascular disease, diabetes, and cancer is expected to create a huge demand for prefilled syringes in the market. According to the World Health Organization, it was estimated that around 17.9 million people died due to the increasing cases of cardiovascular disease which represents around 32% of all global deaths.

Additionally, growing cases of diarrheal disease are further anticipated to drive the overall market growth. According to the World Health Organization, diarrhoeal disease kills around 525,000 children under five every year. It is a leading cause of child mortality in the world which results from malnutrition and contaminated food and water sources. Worldwide, 780 million individuals lack access to drinking water, and 2.5 billion lack improved sanitation.

Key developments

September 2023- Cardinal Health has announced the launch of the Kangaroo OMNI enteral feeding pump, offering patients more personalized options for their enteral feeding journey. The first and attitude-independent enteral feeding system in the US, Kangaroo OMNI delivers thick, homogenized, and blended formulas. Its compact size, versatility to feed, flush, and hydrate, and 30-day feeding history make it a convenient pump for patients and caregivers, from hospital to home. The pump is designed to meet the needs of patients and caregivers.
November 2022- Medela has donated products to 60 Ronald McDonald House locations in Australia, China, the UK, and the USA to improve maternal and infant health outcomes. The donation will support 15,000 breastfeeding families and includes Symphony breast pumps, kits, and accessories. Medela also partnered with Ronald McDonald House Charities to donate NICU supplies under its breastfeeding business unit. The company's focus is on fighting infant mortality and malnutrition, protecting vulnerable infants, increasing access to quality healthcare, education, and resources, and promoting gender equality and inclusion.

North America is anticipated to dominate the overall market

Geographically, the global enteral feeding devices market has been classified into North America, Europe, the Middle East and Africa, South America, and the Asia Pacific. Countries like India and China are anticipated to have considerable market growth during the forecast period. The growth is attributed due to the rise in the prevalence of diabetes, India has 77 million people that are suffering from diabetes in the 20-79 years age group followed by China which has 116 million adults with diabetes. The growth is mainly contributed by the countries that lie in the western pacific and southeast Asia (Source: IDF). North America is anticipated to dominate the overall market growth due to the rising adoption of this device followed by advanced treatment approaches in healthcare. Moreover, the high prevalence of the chronic disease across the region will further increase the demand for enteral feeding devices. In 2020, an estimated 1.86 million cases of cancer were diagnosed in the United States and more than 55,000 people died from the disease (Source: National Cancer Institute). The enteral feeding devices market in North America is projected to be driven by favorable funding from the government and continuous research, prevention, and treatment in the United States.

Market Segments

By Type

Enteral Feeding Pumps
Enteral Feeding Tubes
Enteral Syringes

By Age Group

Adult
Pediatric

By Application

Gastroenterology
Oncology
Neurology
Hypermetabolism
Diabetes
Others

By End-User

Hospitals
Home Care
Ambulatory Care Settings

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
U.K.
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
India
South Korea
Taiwan
Thailand
Indonesia
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings
3.2. CXO Perspective

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View

5. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY TYPE

5.1. Introduction
5.2. Enteral Feeding Pumps
- 5.2.1. Market Opportunities and Trends
- 5.2.2. Growth Prospects
- 5.2.3. Geographic Lucrativeness
5.3. Enteral Feeding Tubes
- 5.3.1. Market Opportunities and Trends
- 5.3.2. Growth Prospects
- 5.3.3. Geographic Lucrativeness
5.4. Enteral Syringes
- 5.4.1. Market Opportunities and Trends
- 5.4.2. Growth Prospects
- 5.4.3. Geographic Lucrativeness

6. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP

6.1. Introduction
6.2. Adult
- 6.2.1. Market Opportunities and Trends
- 6.2.2. Growth Prospects
- 6.2.3. Geographic Lucrativeness
6.3. Paediatric
- 6.3.1. Market Opportunities and Trends
- 6.3.2. Growth Prospects
- 6.3.3. Geographic Lucrativeness

7. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY APPLICATION

7.1. Introduction
7.2. Gastroenterology
- 7.2.1. Market Opportunities and Trends
- 7.2.2. Growth Prospects
- 7.2.3. Geographic Lucrativeness
7.3. Oncology
- 7.3.1. Market Opportunities and Trends
- 7.3.2. Growth Prospects
- 7.3.3. Geographic Lucrativeness
7.4. Neurology
- 7.4.1. Market Opportunities and Trends
- 7.4.2. Growth Prospects
- 7.4.3. Geographic Lucrativeness
7.5. Hypermetabolism
- 7.5.1. Market Opportunities and Trends
- 7.5.2. Growth Prospects
- 7.5.3. Geographic Lucrativeness
7.6. Diabetes
- 7.6.1. Market Opportunities and Trends
- 7.6.2. Growth Prospects
- 7.6.3. Geographic Lucrativeness
7.7. Others
- 7.7.1. Market Opportunities and Trends
- 7.7.2. Growth Prospects
- 7.7.3. Geographic Lucrativeness

8. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY END-USER

8.1. Introduction
8.2. Hospitals
- 8.2.1. Market Opportunities and Trends
- 8.2.2. Growth Prospects
- 8.2.3. Geographic Lucrativeness
8.3. Home Care
- 8.3.1. Market Opportunities and Trends
- 8.3.2. Growth Prospects
- 8.3.3. Geographic Lucrativeness
8.4. Ambulatory Care Settings
- 8.4.1. Market Opportunities and Trends
- 8.4.2. Growth Prospects
- 8.4.3. Geographic Lucrativeness

9. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY GEOGRAPHY

9.1. Introduction
9.2. North America
- 9.2.1. By Type
- 9.2.2. By Age Group
- 9.2.3. By Application
- 9.2.4. By End User
- 9.2.5. By Country
  - 9.2.5.1. United States
    - 9.2.5.1.1. Market Opportunities and Trends
    - 9.2.5.1.2. Growth Prospects
  - 9.2.5.2. Canada
    - 9.2.5.2.1. Market Opportunities and Trends
    - 9.2.5.2.2. Growth Prospects
  - 9.2.5.3. Mexico
    - 9.2.5.3.1. Market Opportunities and Trends
    - 9.2.5.3.2. Growth Prospects
9.3. South America
- 9.3.1. By Type
- 9.3.2. By Age Group
- 9.3.3. By Application
- 9.3.4. By End User
- 9.3.5. By Country
  - 9.3.5.1. Brazil
    - 9.3.5.1.1. Market Opportunities and Trends
    - 9.3.5.1.2. Growth Prospects
  - 9.3.5.2. Argentina
    - 9.3.5.2.1. Market Opportunities and Trends
    - 9.3.5.2.2. Growth Prospects
  - 9.3.5.3. Others
    - 9.3.5.3.1. Market Opportunities and Trends
    - 9.3.5.3.2. Growth Prospects
9.4. Europe
- 9.4.1. By Type
- 9.4.2. By Age Group
- 9.4.3. By Application
- 9.4.4. By End User
- 9.4.5. By Country
  - 9.4.5.1. United Kingdom
    - 9.4.5.1.1. Market Opportunities and Trends
    - 9.4.5.1.2. Growth Prospects
  - 9.4.5.2. Germany
    - 9.4.5.2.1. Market Opportunities and Trends
    - 9.4.5.2.2. Growth Prospects
  - 9.4.5.3. France
    - 9.4.5.3.1. Market Opportunities and Trends
    - 9.4.5.3.2. Growth Prospects
  - 9.4.5.4. Italy
    - 9.4.5.4.1. Market Opportunities and Trends
    - 9.4.5.4.2. Growth Prospects
  - 9.4.5.5. Spain
    - 9.4.5.5.1. Market Opportunities and Trends
    - 9.4.5.5.2. Growth Prospects
  - 9.4.5.6. Others
    - 9.4.5.6.1. Market Opportunities and Trends
    - 9.4.5.6.2. Growth Prospects
9.5. Middle East and Africa
- 9.5.1. By Type
- 9.5.2. By Age Group
- 9.5.3. By Application
- 9.5.4. By End User
- 9.5.5. By Country
  - 9.5.5.1. Saudi Arabia
    - 9.5.5.1.1. Market Opportunities and Trends
    - 9.5.5.1.2. Growth Prospects
  - 9.5.5.2. UAE
    - 9.5.5.2.1. Market Opportunities and Trends
    - 9.5.5.2.2. Growth Prospects
  - 9.5.5.3. Others
    - 9.5.5.3.1. Market Opportunities and Trends
    - 9.5.5.3.2. Growth Prospects
9.6. Asia Pacific
- 9.6.1. By Type
- 9.6.2. By Age Group
- 9.6.3. By Application
- 9.6.4. By End User
- 9.6.5. By Country
  - 9.6.5.1. Japan
    - 9.6.5.1.1. Market Opportunities and Trends
    - 9.6.5.1.2. Growth Prospects
  - 9.6.5.2. China
    - 9.6.5.2.1. Market Opportunities and Trends
    - 9.6.5.2.2. Growth Prospects
  - 9.6.5.3. India
    - 9.6.5.3.1. Market Opportunities and Trends
    - 9.6.5.3.2. Growth Prospects
  - 9.6.5.4. South Korea
    - 9.6.5.4.1. Market Opportunities and Trends
    - 9.6.5.4.2. Growth Prospects
  - 9.6.5.5. Taiwan
    - 9.6.5.5.1. Market Opportunities and Trends
    - 9.6.5.5.2. Growth Prospects
  - 9.6.5.6. Thailand
    - 9.6.5.6.1. Market Opportunities and Trends
    - 9.6.5.6.2. Growth Prospects
  - 9.6.5.7. Indonesia
    - 9.6.5.7.1. Market Opportunities and Trends
    - 9.6.5.7.2. Growth Prospects
  - 9.6.5.8. Others
    - 9.6.5.8.1. Market Opportunities and Trends
    - 9.6.5.8.2. Growth Prospects